![]() |
Name |
Aristolene
|
Molecular Formula | C15H24 | |
IUPAC Name* |
1,1,7,7a-tetramethyl-2,4,5,6,7,7b-hexahydro-1aH-cyclopropa[a]naphthalene
|
|
SMILES |
CC1CCCC2=CCC3C(C12C)C3(C)C
|
|
InChI |
InChI=1S/C15H24/c1-10-6-5-7-11-8-9-12-13(14(12,2)3)15(10,11)4/h8,10,12-13H,5-7,9H2,1-4H3
|
|
InChIKey |
FOBXOZMHEKILEY-UHFFFAOYSA-N
|
|
Synonyms |
Aristolene; (-)-Aristolene; Aristol-9-ene; 1,1,7,7a-tetramethyl-1H,1aH,2H,4H,5H,6H,7H,7aH,7bH-cyclopropa[a]naphthalene; Aristolen; 9-Aristolene; Aristol-9-ene #; (-)-9-Aristolene; CHEBI:167397; 1,1,7,7a-tetramethyl-2,4,5,6,7,7b-hexahydro-1aH-cyclopropa[a]naphthalene; Q67879695
|
|
CAS | 6831-16-9 | |
PubChem CID | 530421 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 204.35 | ALogp: | 4.7 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 0.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 15 | QED Weighted: | 0.491 |
Caco-2 Permeability: | -4.492 | MDCK Permeability: | 0.00001260 |
Pgp-inhibitor: | 0.081 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.064 |
30% Bioavailability (F30%): | 0.184 |
Blood-Brain-Barrier Penetration (BBB): | 0.743 | Plasma Protein Binding (PPB): | 94.28% |
Volume Distribution (VD): | 2.784 | Fu: | 5.03% |
CYP1A2-inhibitor: | 0.291 | CYP1A2-substrate: | 0.594 |
CYP2C19-inhibitor: | 0.439 | CYP2C19-substrate: | 0.921 |
CYP2C9-inhibitor: | 0.393 | CYP2C9-substrate: | 0.759 |
CYP2D6-inhibitor: | 0.06 | CYP2D6-substrate: | 0.75 |
CYP3A4-inhibitor: | 0.318 | CYP3A4-substrate: | 0.339 |
Clearance (CL): | 14.487 | Half-life (T1/2): | 0.042 |
hERG Blockers: | 0.002 | Human Hepatotoxicity (H-HT): | 0.157 |
Drug-inuced Liver Injury (DILI): | 0.033 | AMES Toxicity: | 0.004 |
Rat Oral Acute Toxicity: | 0.093 | Maximum Recommended Daily Dose: | 0.514 |
Skin Sensitization: | 0.051 | Carcinogencity: | 0.119 |
Eye Corrosion: | 0.061 | Eye Irritation: | 0.364 |
Respiratory Toxicity: | 0.916 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001834 | ![]() |
0.673 | D0K0EK | ![]() |
0.282 | ||
ENC000949 | ![]() |
0.585 | D0D2TN | ![]() |
0.267 | ||
ENC001829 | ![]() |
0.439 | D0B4RU | ![]() |
0.265 | ||
ENC001437 | ![]() |
0.439 | D0Z1XD | ![]() |
0.259 | ||
ENC001078 | ![]() |
0.403 | D0V8HA | ![]() |
0.259 | ||
ENC001831 | ![]() |
0.367 | D0H1QY | ![]() |
0.250 | ||
ENC000965 | ![]() |
0.355 | D0L2LS | ![]() |
0.247 | ||
ENC003074 | ![]() |
0.355 | D0I5DS | ![]() |
0.239 | ||
ENC001321 | ![]() |
0.344 | D04SFH | ![]() |
0.239 | ||
ENC003215 | ![]() |
0.344 | D0I2SD | ![]() |
0.239 |